SG11201803489SA
|
|
4-(biphen-3-yl)-1h-pyrazolo[3,4-c]pyridazine derivatives of formula (i) as gaba receptor modulators for use in the treatment of epilepsy and pain
|
WO2016034971A1
|
|
Sulfonamides derivatives as urat1 inhibitors
|
WO2015189744A1
|
|
Imidazopyridazine derivatives as modulators of the gabaa receptor activity.
|
US2015159134A1
|
|
Method for producing retinal pigment epithelial cells
|
US2017305857A1
|
|
N-acylpiperidine ether tropomyosin-related kinase inhibitors
|
AU2014363032A1
|
|
Method for producing retinal pigment epithelial cells
|
TW201443025A
|
|
Chemical compounds
|
TW201512171A
|
|
Chemical compounds
|
GEP201706710B
|
|
Imidazopyridazine derivatives as gabaa receptor modulators
|
EP2912036A1
|
|
Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors
|
CA2885253A1
|
|
Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors
|
CA2885247A1
|
|
Tropomyosin-related kinase inhibitors
|
AU2013202985A1
|
|
Treatment of interstitial cystitis
|
EP2800740A1
|
|
N-aminosulfonyl benzamides
|
EP2791108A1
|
|
Sulfonamide derivatives
|
WO2013093688A1
|
|
Sulfonamide derivatives and use thereof as vgsc inhibitors
|
GB201219296D0
|
|
Pyrazole derivatives
|
WO2013061297A1
|
|
Pyridazine Derivatives Useful in Therapy
|
GB201219289D0
|
|
Pyrazole derivatives
|
JP2013087119A
|
|
Novel salt and medical use
|